Specific Compounds of formula (I): or pharmaceutically acceptable salts thereof, wherein m, X, R, R2, R3, R, R6 and R7 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
具有以下
化学式(I)的特定化合物:或其药用可接受的盐,其中m、X、R、R2、R3、R、R6和R7如本文所定义。还公开了制备这些化合物的方法,并使用这些化合物治疗与LRRK2受体相关的疾病,如帕
金森病。